These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 17325653

  • 1. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
    Thors L, Alajakku K, Fowler CJ.
    Br J Pharmacol; 2007 Apr; 150(7):951-60. PubMed ID: 17325653
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
    Thors L, Eriksson J, Fowler CJ.
    Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S, Fowler CJ.
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK, Kidd SR, Moore SA, Schaus JM, Liu B, Nomikos GG, Felder CC.
    Cell Mol Neurobiol; 2006 Apr; 26(4-6):407-23. PubMed ID: 16736384
    [Abstract] [Full Text] [Related]

  • 12. Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin.
    Sandberg A, Fowler CJ.
    Chem Phys Lipids; 2005 Apr; 134(2):131-9. PubMed ID: 15784231
    [Abstract] [Full Text] [Related]

  • 13. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N.
    Biochim Biophys Acta; 2005 Oct 01; 1736(3):211-20. PubMed ID: 16154384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
    Nicolussi S, Chicca A, Rau M, Rihs S, Soeberdt M, Abels C, Gertsch J.
    Biochem Pharmacol; 2014 Dec 15; 92(4):669-89. PubMed ID: 25283614
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.